Japan Radiotherapy Market

Market Overview:

Japan radiotherapy market size reached USD 444.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 719.5 Million by 2033, exhibiting a growth rate (CAGR) of 5.28% during 2025-2033. The inflating healthcare expenditure capacities, along with the growing need for effective treatment methods that relieve symptoms of advanced cancers, are primarily driving the market growth.

Radiotherapy, alternatively referred to as radiation therapy, serves the purpose of retarding the proliferation of cancer cells and reducing the size of tumors. This treatment modality disrupts the genetic material within cancer cells through the utilization of high-energy particles or waves, encompassing options like x-rays, gamma rays, electron beams, or protons. In many cases, it is employed in conjunction with other cancer therapies such as surgery, chemotherapy, and immunotherapy to enhance their efficacy. In line with this, the decision to administer radiotherapy to patients hinges on factors such as the specific cancer type, the tumor's dimensions and location, the patient's medical history, age, and overall health conditions. Consequently, it is used in hospitals across Japan.

Japan Radiotherapy Market Trends:

The increasing incidence of cancer due to unhealthy dietary habits, insufficient physical activity, rising air pollution levels, and the growing consumption of alcohol and tobacco constitutes a major factor driving market growth in Japan. Furthermore, the risk of cancer development significantly escalates with age, as cellular repair mechanisms become less effective in older individuals. Consequently, the increasing elderly population in Japan is acting as another substantial catalyst for market expansion. Additionally, the advancement of cost-effective, user-friendly radiotherapy products is further augmenting market growth. Furthermore, modern radiotherapy techniques like three-dimensional (3D) conformal, intensity-modulated, and image-guided approaches deliver a higher radiation dose to tumors while minimizing exposure to healthy tissues, enhancing the protection of critical organs, and providing patients with a painless experience, which is acting as another significant growth-inducing factor. These techniques are gaining traction across various applications and healthcare settings for the treatment of chronic diseases, consequently driving global demand for radiotherapy. Moreover, the market is poised for growth due to the escalating healthcare expenditure in both developed and emerging economies within Japan. All these factors are expected to propel the regional market in the coming years.

Japan Radiotherapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on type, application, and end user.

Type Insights:

• External Beam Radiation Therapy 
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Image-Guided Radiation Therapy (IGRT)
  • Tomotherapy
  • Stereotactic Radiosurgery
  • Stereotactic Body Radiation Therapy
  • Proton Therapy
  • 3D Conformal Radiotherapy (3D CRT)
  • Volumetric Modulated Arc Therapy (VMAT)
• Internal Radiation Therapy/Brachytherapy
• Systemic Radiation Therapy
   

The report has provided a detailed breakup and analysis of the market based on the type. This includes external beam radiation therapy (intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), tomotherapy, stereotactic radiosurgery, stereotactic body radiation therapy, proton therapy, 3D conformal radiotherapy (3D CRT), and volumetric modulated arc therapy (VMAT)), internal radiation therapy/brachytherapy, and systemic radiation therapy.

Application Insights:

• Skin and Lip Cancer
• Head and Neck Cancer
• Breast Cancer
• Prostate Cancer
• Cervical Cancer
• Lung Cancer
• Others
   

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes skin and lip cancer, head and neck cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, and others.

End User Insights:

• Hospitals
• Cancer Research Institutes
• Ambulatory and Radiotherapy Centers
   

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, cancer research institutes, and ambulatory and radiotherapy centers.

Regional Insights:

• Kanto Region
• Kansai/Kinki Region
• Central/ Chubu Region
• Kyushu-Okinawa Region
• Tohoku Region
• Chugoku Region
• Hokkaido Region
• Shikoku Region
   

The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

• Elekta K.K. (Elekta)
• Hitachi Ltd.
• Osaka Heavy Ion Therapy Center
• Sumitomo Heavy Industries Ltd.
• Toshiba Corporation
   

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Japan Radiotherapy Market Report Coverage:

Key Questions Answered in This Report:

• How has the Japan radiotherapy market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan radiotherapy market?
• What is the breakup of the Japan radiotherapy market on the basis of type?
• What is the breakup of the Japan radiotherapy market on the basis of application?
• What is the breakup of the Japan radiotherapy market on the basis of end user?
• What are the various stages in the value chain of the Japan radiotherapy market? 
• What are the key driving factors and challenges in the Japan radiotherapy?
• What is the structure of the Japan radiotherapy market and who are the key players?
• What is the degree of competition in the Japan radiotherapy market?

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Japan radiotherapy market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Japan radiotherapy market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Japan radiotherapy industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.